Edition:
India

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

29.92USD
22 Aug 2019
Change (% chg)

-- (--)
Prev Close
$29.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
131,767
52-wk High
$30.24
52-wk Low
$11.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -1.124
Mar '19 0.00 -0.874
FY 2018 Dec '18 0.00 -0.648
Sep '18 0.00 -0.640
Jun '18 0.00 -0.609
Mar '18 0.00 -0.432
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.235
Jun '17 0.00 -0.246
Mar '17 0.00 -0.184
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 4 0.00 0.00 0.00 0.00
Quarter Ending Dec-19 4 0.00 0.00 0.00 0.00
Year Ending Dec-19 5 0.00 0.00 0.00 0.00
Year Ending Dec-20 5 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-19 6 -1.00 -0.91 -1.07 -0.76
Quarter Ending Dec-19 6 -1.02 -0.85 -1.12 -0.81
Year Ending Dec-19 6 -3.98 -3.77 -4.20 -2.57
Year Ending Dec-20 6 -4.17 -3.37 -4.70 -2.64
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.89 32.67
P/E High - Last 5 Yrs. -- 42.97 47.29
P/E Low - Last 5 Yrs. -- 23.36 23.87
Beta -- 0.89 0.89
Price to Sales (TTM) -- 6.25 7.91
Price to Book (MRQ) -- 5.26 5.38
Price to Tangible Book (MRQ) -- 5.93 6.71
Price to Cash Flow (TTM) -- 23.51 24.37
% Owned Institutions -- 0.75 1.45

Dividends

  Company industry sector
Dividend Yield -- 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.44 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) -- 42.60 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.12 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 6.49 7.74
Sales - 5 Yr. Growth Rate -- 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 40.63 42.99
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.78 10.32
Capital Spending - 5 Yr. Growth Rate -- 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.21
Current Ratio (MRQ) -- 2.93 3.03
LT Debt to Equity (MRQ) -- 7.95 10.20
Total Debt to Equity (MRQ) -- 11.64 14.55
Interest Coverage (TTM) -- 33.56 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.86 52.23
Gross Margin - 5 Yr. Avg. -- 49.68 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.37 13.13
Operating Margin (TTM) -- 13.80 6.91
Operating Margin - 5 Yr. Avg. -- 13.92 8.93
Pre-Tax Margin (TTM) -- 12.44 6.12
Pre-Tax Margin - 5 Yr. Avg. -- 14.33 9.23
Net Profit Margin (TTM) -- 9.23 2.75
Net Profit Margin - 5 Yr. Avg. -- 10.76 5.60
Effective Tax Rate (TTM) -- 22.43 22.40
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 992,948,965 887,152,306
Net Income/Employee (TTM) -- 114,014,787 101,829,303
Receivable Turnover (TTM) -- 5.96 5.93
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) -- 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.51 11.17
Return on Assets - 5 Yr. Avg. -- 12.96 12.34
Return on Investment (TTM) -- 14.89 14.48
Return on Investment - 5 Yr. Avg. -- 16.86 16.02
Return on Equity (TTM) -- 16.01 15.78
Return on Equity - 5 Yr. Avg. -- 17.66 17.01

Performance for Apellis Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -- -- -- 25
13 Week -- -- -- 42
26 Week -- -- -- 42
52 Week -- -- -- 12
YTD -- -- -- 38
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 66.12%
# of Holders: 155
Total Shares Held: 42,113,181
3 Mo. Net Change: 375,439
# New Positions: 26
# Closed Positions: 13
# Increased Positions: 94
# Reduced Positions: 40
# Net Buyers: 54
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.